434 related articles for article (PubMed ID: 18511457)
1. Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy.
Kimura E; Han JJ; Li S; Fall B; Ra J; Haraguchi M; Tapscott SJ; Chamberlain JS
Hum Mol Genet; 2008 Aug; 17(16):2507-17. PubMed ID: 18511457
[TBL] [Abstract][Full Text] [Related]
2. Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models.
Quenneville SP; Chapdelaine P; Skuk D; Paradis M; Goulet M; Rousseau J; Xiao X; Garcia L; Tremblay JP
Mol Ther; 2007 Feb; 15(2):431-8. PubMed ID: 17235323
[TBL] [Abstract][Full Text] [Related]
3. Dystrophin delivery to muscles of mdx mice using lentiviral vectors leads to myogenic progenitor targeting and stable gene expression.
Kimura E; Li S; Gregorevic P; Fall BM; Chamberlain JS
Mol Ther; 2010 Jan; 18(1):206-13. PubMed ID: 19888194
[TBL] [Abstract][Full Text] [Related]
4. Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice.
Fakhfakh R; Michaud A; Tremblay JP
Mol Ther; 2011 Jan; 19(1):204-10. PubMed ID: 20700111
[TBL] [Abstract][Full Text] [Related]
5. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.
Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS
Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 editing of directly reprogrammed myogenic progenitors restores dystrophin expression in a mouse model of muscular dystrophy.
Domenig SA; Bundschuh N; Lenardič A; Ghosh A; Kim I; Qabrati X; D'Hulst G; Bar-Nur O
Stem Cell Reports; 2022 Feb; 17(2):321-336. PubMed ID: 34995499
[TBL] [Abstract][Full Text] [Related]
7. High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies.
Lattanzi L; Salvatori G; Coletta M; Sonnino C; Cusella De Angelis MG; Gioglio L; Murry CE; Kelly R; Ferrari G; Molinaro M; Crescenzi M; Mavilio F; Cossu G
J Clin Invest; 1998 May; 101(10):2119-28. PubMed ID: 9593768
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of myogenic and muscle repair capacities of human adipose-derived stem cells with forced expression of MyoD.
Goudenege S; Pisani DF; Wdziekonski B; Di Santo JP; Bagnis C; Dani C; Dechesne CA
Mol Ther; 2009 Jun; 17(6):1064-72. PubMed ID: 19352326
[TBL] [Abstract][Full Text] [Related]
9. Transplantation of Dystrophin Expressing Chimeric Human Cells of Myoblast/Mesenchymal Stem Cell Origin Improves Function in Duchenne Muscular Dystrophy Model.
Siemionow M; Szilagyi E; Cwykiel J; Domaszewska-Szostek A; Heydemann A; Garcia-Martinez J; Siemionow K
Stem Cells Dev; 2021 Feb; 30(4):190-202. PubMed ID: 33349121
[TBL] [Abstract][Full Text] [Related]
10. Immortalized skin fibroblasts expressing conditional MyoD as a renewable and reliable source of converted human muscle cells to assess therapeutic strategies for muscular dystrophies: validation of an exon-skipping approach to restore dystrophin in Duchenne muscular dystrophy cells.
Chaouch S; Mouly V; Goyenvalle A; Vulin A; Mamchaoui K; Negroni E; Di Santo J; Butler-Browne G; Torrente Y; Garcia L; Furling D
Hum Gene Ther; 2009 Jul; 20(7):784-90. PubMed ID: 19358679
[TBL] [Abstract][Full Text] [Related]
11. MyoD Overexpressed Equine Adipose-Derived Stem Cells Enhanced Myogenic Differentiation Potential.
Sung SE; Hwang M; Kim AY; Lee EM; Lee EJ; Hwang SK; Kim SY; Kim HK; Jeong KS
Cell Transplant; 2016 Nov; 25(11):2017-2026. PubMed ID: 26892394
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo tetracycline-controlled myogenic conversion of NIH-3T3 cells: evidence of programmed cell death after muscle cell transplantation.
Del Bo R; Torrente Y; Corti S; D'Angelo MG; Comi GP; Fagiolari G; Salani S; Cova A; Pisati F; Moggio M; Ausenda C; Scarlato G; Bresolin N
Cell Transplant; 2001; 10(2):209-21. PubMed ID: 11332636
[TBL] [Abstract][Full Text] [Related]
13. Sunitinib promotes myogenic regeneration and mitigates disease progression in the mdx mouse model of Duchenne muscular dystrophy.
Fontelonga TM; Jordan B; Nunes AM; Barraza-Flores P; Bolden N; Wuebbles RD; Griner LM; Hu X; Ferrer M; Marugan J; Southall N; Burkin DJ
Hum Mol Genet; 2019 Jul; 28(13):2120-2132. PubMed ID: 30806670
[TBL] [Abstract][Full Text] [Related]
14. Autologous skeletal muscle derived cells expressing a novel functional dystrophin provide a potential therapy for Duchenne Muscular Dystrophy.
Meng J; Counsell JR; Reza M; Laval SH; Danos O; Thrasher A; Lochmüller H; Muntoni F; Morgan JE
Sci Rep; 2016 Jan; 6():19750. PubMed ID: 26813695
[TBL] [Abstract][Full Text] [Related]
15. Restoration of Functional Full-Length Dystrophin After Intramuscular Transplantation of Foamy Virus-Transduced Myoblasts.
Meng J; Sweeney NP; Doreste B; Muntoni F; McClure M; Morgan J
Hum Gene Ther; 2020 Feb; 31(3-4):241-252. PubMed ID: 31801386
[TBL] [Abstract][Full Text] [Related]
16. Effects of Mini-Dystrophin on Dystrophin-Deficient, Human Skeletal Muscle-Derived Cells.
Meng J; Counsell J; Morgan JE
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998454
[TBL] [Abstract][Full Text] [Related]
17. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy.
He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C
Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065
[TBL] [Abstract][Full Text] [Related]
18. Fetal skeletal muscle progenitors have regenerative capacity after intramuscular engraftment in dystrophin deficient mice.
Sakai H; Sato T; Sakurai H; Yamamoto T; Hanaoka K; Montarras D; Sehara-Fujisawa A
PLoS One; 2013; 8(5):e63016. PubMed ID: 23671652
[TBL] [Abstract][Full Text] [Related]
19. Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation.
Cui CH; Uyama T; Miyado K; Terai M; Kyo S; Kiyono T; Umezawa A
Mol Biol Cell; 2007 May; 18(5):1586-94. PubMed ID: 17314403
[TBL] [Abstract][Full Text] [Related]
20. Engraftment potential of dermal fibroblasts following in vivo myogenic conversion in immunocompetent dystrophic skeletal muscle.
Muir LA; Nguyen QG; Hauschka SD; Chamberlain JS
Mol Ther Methods Clin Dev; 2014 Jun; 1():14025. PubMed ID: 25558461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
